-
-
-
-
-
-
-
Ultragenyx Reports First Quarter 2026 Financial Results and Corporate Update
-
-
-
-
-
-
-
William Blair Reiterates Outperform Rating on Ultragenyx Pharma (RARE)
-
-
-
-
-
-
-
Ultragenyx and Mereo BioPharma Announce UX143 Phase 3 Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis
-
-
-
-
-
-
-
Ultragenyx Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Update
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) Tops Q2 EPS by 14c; offers guidance
-
-
-
-
-
-
-
Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update
-
-
-
-
-
-
-
Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments
-
1,218,674 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

